416 related articles for article (PubMed ID: 20860481)
1. Immune evasion by Kaposi's sarcoma-associated herpesvirus.
Lee HR; Lee S; Chaudhary PM; Gill P; Jung JU
Future Microbiol; 2010 Sep; 5(9):1349-65. PubMed ID: 20860481
[TBL] [Abstract][Full Text] [Related]
2. Modulation of Immune System by Kaposi's Sarcoma-Associated Herpesvirus: Lessons from Viral Evasion Strategies.
Lee HR; Brulois K; Wong L; Jung JU
Front Microbiol; 2012; 3():44. PubMed ID: 22403573
[TBL] [Abstract][Full Text] [Related]
3. Genotypic and clinicopathological characterization of Kaposi's sarcoma-associated herpesvirus infection in Japan.
Kanno T; Sato Y; Nakamura T; Sakamoto K; Sata T; Katano H
J Med Virol; 2010 Mar; 82(3):400-6. PubMed ID: 20087946
[TBL] [Abstract][Full Text] [Related]
4. Immune evasion in Kaposi's sarcoma-associated herpes virus associated oncogenesis.
Liang C; Lee JS; Jung JU
Semin Cancer Biol; 2008 Dec; 18(6):423-36. PubMed ID: 18948197
[TBL] [Abstract][Full Text] [Related]
5. Linking the Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8) to human malignancies.
Kalt I; Masa SR; Sarid R
Methods Mol Biol; 2009; 471():387-407. PubMed ID: 19109790
[TBL] [Abstract][Full Text] [Related]
6. Kaposi's sarcoma-associated herpesvirus and extracellular vesicles.
Barrett L; Dai L; Wang S; Qin Z
J Med Virol; 2021 Jun; 93(6):3294-3299. PubMed ID: 33415746
[TBL] [Abstract][Full Text] [Related]
7. [Replication Machinery of Kaposi's Sarcoma-associated Herpesvirus and Drug Discovery Research].
Watanabe T; Fujimuro M
Yakugaku Zasshi; 2019; 139(1):69-73. PubMed ID: 30606932
[TBL] [Abstract][Full Text] [Related]
8. Kaposi's Sarcoma-Associated Herpesvirus Viral Interleukin-6 Signaling Upregulates Integrin β3 Levels and Is Dependent on STAT3.
Rivera-Soto R; Dissinger NJ; Damania B
J Virol; 2020 Feb; 94(5):. PubMed ID: 31801855
[TBL] [Abstract][Full Text] [Related]
9. Kaposi's Sarcoma-Associated Herpesvirus Latency Locus Renders B Cells Hyperresponsive to Secondary Infections.
Sin SH; Eason AB; Bigi R; Kim Y; Kang S; Tan K; Seltzer TA; Venkataramanan R; An H; Dittmer DP
J Virol; 2018 Oct; 92(19):. PubMed ID: 30021906
[TBL] [Abstract][Full Text] [Related]
10. Towards Better Understanding of KSHV Life Cycle: from Transcription and Posttranscriptional Regulations to Pathogenesis.
Yan L; Majerciak V; Zheng ZM; Lan K
Virol Sin; 2019 Apr; 34(2):135-161. PubMed ID: 31025296
[TBL] [Abstract][Full Text] [Related]
11. Pathological Features of Kaposi's Sarcoma-Associated Herpesvirus Infection.
Katano H
Adv Exp Med Biol; 2018; 1045():357-376. PubMed ID: 29896675
[TBL] [Abstract][Full Text] [Related]
12. Regulation of KSHV Latency and Lytic Reactivation.
Broussard G; Damania B
Viruses; 2020 Sep; 12(9):. PubMed ID: 32957532
[TBL] [Abstract][Full Text] [Related]
13. Latent Kaposi's sarcoma-associated herpesvirus infection of monocytes downregulates expression of adaptive immune response costimulatory receptors and proinflammatory cytokines.
Gregory SM; Wang L; West JA; Dittmer DP; Damania B
J Virol; 2012 Apr; 86(7):3916-23. PubMed ID: 22278234
[TBL] [Abstract][Full Text] [Related]
14. Altering the Anti-inflammatory Lipoxin Microenvironment: a New Insight into Kaposi's Sarcoma-Associated Herpesvirus Pathogenesis.
Chandrasekharan JA; Huang XM; Hwang AC; Sharma-Walia N
J Virol; 2016 Dec; 90(24):11020-11031. PubMed ID: 27681120
[TBL] [Abstract][Full Text] [Related]
15. Immune evasion by Kaposi's sarcoma-associated herpesvirus.
Coscoy L
Nat Rev Immunol; 2007 May; 7(5):391-401. PubMed ID: 17457345
[TBL] [Abstract][Full Text] [Related]
16. Interplay between Kaposi's sarcoma-associated herpesvirus and the innate immune system.
Brulois K; Jung JU
Cytokine Growth Factor Rev; 2014 Oct; 25(5):597-609. PubMed ID: 25037686
[TBL] [Abstract][Full Text] [Related]
17. Nuclear Localization and Cleavage of STAT6 Is Induced by Kaposi's Sarcoma-Associated Herpesvirus for Viral Latency.
Wang C; Zhu C; Wei F; Gao S; Zhang L; Li Y; Feng Y; Tong Y; Xu J; Wang B; Yuan Z; Robertson ES; Cai Q
PLoS Pathog; 2017 Jan; 13(1):e1006124. PubMed ID: 28099521
[TBL] [Abstract][Full Text] [Related]
18. Repurposing Cytarabine for Treating Primary Effusion Lymphoma by Targeting Kaposi's Sarcoma-Associated Herpesvirus Latent and Lytic Replications.
Gruffaz M; Zhou S; Vasan K; Rushing T; Michael QL; Lu C; Jung JU; Gao SJ
mBio; 2018 May; 9(3):. PubMed ID: 29739902
[TBL] [Abstract][Full Text] [Related]
19. Identification of Novel Kaposi's Sarcoma-Associated Herpesvirus Orf50 Transcripts: Discovery of New RTA Isoforms with Variable Transactivation Potential.
Wakeman BS; Izumiya Y; Speck SH
J Virol; 2017 Jan; 91(1):. PubMed ID: 27795414
[TBL] [Abstract][Full Text] [Related]
20. Adaptive immune responses to Kaposi's sarcoma-associated herpesvirus.
Nalwoga A; Whitby D
Curr Opin Immunol; 2022 Aug; 77():102230. PubMed ID: 35810680
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
